William D. Zollars Sells 212 Shares of CIGNA Co. (CI) Stock

CIGNA Co. (NYSE:CI) Director William D. Zollars sold 212 shares of the firm’s stock in a transaction that occurred on Wednesday, January 10th. The stock was sold at an average price of $205.68, for a total value of $43,604.16. Following the sale, the director now directly owns 13,500 shares of the company’s stock, valued at approximately $2,776,680. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Shares of CIGNA Co. (NYSE:CI) opened at $213.39 on Friday. The company has a quick ratio of 0.39, a current ratio of 0.39 and a debt-to-equity ratio of 0.37. CIGNA Co. has a one year low of $133.52 and a one year high of $213.73. The company has a market capitalization of $52,611.30, a P/E ratio of 23.37, a price-to-earnings-growth ratio of 1.45 and a beta of 0.51.

CIGNA (NYSE:CI) last announced its quarterly earnings data on Thursday, November 2nd. The health services provider reported $2.83 EPS for the quarter, beating the Zacks’ consensus estimate of $2.36 by $0.47. CIGNA had a return on equity of 18.85% and a net margin of 5.74%. The firm had revenue of $10.38 billion during the quarter, compared to analysts’ expectations of $10.17 billion. During the same quarter last year, the firm posted $1.94 earnings per share. The company’s revenue for the quarter was up 5.1% compared to the same quarter last year. equities research analysts expect that CIGNA Co. will post 10.34 EPS for the current fiscal year.

A number of institutional investors have recently made changes to their positions in CI. Chicago Equity Partners LLC acquired a new stake in CIGNA in the second quarter valued at approximately $264,000. Northwestern Mutual Wealth Management Co. lifted its holdings in shares of CIGNA by 2.3% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,760 shares of the health services provider’s stock valued at $295,000 after purchasing an additional 40 shares in the last quarter. Riverhead Capital Management LLC lifted its holdings in shares of CIGNA by 159.3% in the second quarter. Riverhead Capital Management LLC now owns 5,511 shares of the health services provider’s stock valued at $923,000 after purchasing an additional 3,386 shares in the last quarter. Norinchukin Bank The lifted its holdings in shares of CIGNA by 6.4% in the second quarter. Norinchukin Bank The now owns 17,766 shares of the health services provider’s stock valued at $2,974,000 after purchasing an additional 1,062 shares in the last quarter. Finally, Dorsey & Whitney Trust CO LLC lifted its holdings in shares of CIGNA by 12.3% in the second quarter. Dorsey & Whitney Trust CO LLC now owns 2,749 shares of the health services provider’s stock valued at $460,000 after purchasing an additional 301 shares in the last quarter. 87.74% of the stock is owned by hedge funds and other institutional investors.

CI has been the subject of several recent analyst reports. Jefferies Group raised their target price on CIGNA from $201.00 to $221.00 and gave the stock a “buy” rating in a research note on Friday, October 13th. Zacks Investment Research raised CIGNA from a “hold” rating to a “buy” rating and set a $214.00 target price for the company in a research note on Monday, October 9th. Piper Jaffray Companies reaffirmed a “buy” rating and set a $191.00 target price on shares of CIGNA in a research note on Sunday, September 17th. Citigroup raised their target price on CIGNA from $198.00 to $231.00 and gave the stock a “buy” rating in a research note on Friday, November 3rd. Finally, ValuEngine raised CIGNA from a “hold” rating to a “buy” rating in a research note on Sunday, December 31st. Three equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company. CIGNA currently has an average rating of “Buy” and a consensus target price of $205.18.

ILLEGAL ACTIVITY NOTICE: “William D. Zollars Sells 212 Shares of CIGNA Co. (CI) Stock” was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece of content on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright law. The correct version of this piece of content can be read at https://www.dispatchtribunal.com/2018/01/14/william-d-zollars-sells-212-shares-of-cigna-co-ci-stock.html.

About CIGNA

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Insider Buying and Selling by Quarter for CIGNA (NYSE:CI)

Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply